Recently, I came across an OIG announcement “Review of Medicare Part B Claims for Intravitreal Injections of Eylea and Lucentis” released in June 2019. Upon reading this announcement, I pulled […]

On October 3, 2018, CMS released CR 10901, Transmittal R829PI, effective October 3, 2018 with an implementation date of January 8, 2019. This is an important modification to the LCD […]